<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE313nnn/GSE313051/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313051</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Positively charged Ce-doped polypyrrole nanoparticles ameliorate acute kidney injury by endo-exogenous regulation of oxidative stress</name><description>Acute kidney injury (AKI) remains a critical clinical challenge with rapid renal function decline and limited therapeutic options. Mitochondrial reactive oxygen species (ROS)-induced oxidative stress drives AKI progression. This study develops a novel nanomedicine strategy utilizing cerium-doped polypyrrole (CePPy) nanoparticles to target ischemia-reperfusion injury-induced AKI. Synthesized via a green, one-step method, CePPy shows broad-spectrum antioxidant properties, and its positive surface charge enhances renal uptake and therapeutic efficacy compared to negatively charged counterparts. We demonstrate that positively charged CePPy (designated (+)CePPy), preferentially accumulates in the mitochondria of injured proximal tubular epithelial cells (PTECs) through transcytosis from peritubular capillaries. The (+)CePPy exhibits strong ROS scavenging capabilities as an exogenous antioxidant, and bolsters endogenous mitochondrial defenses via Mpv17l-dependent mechanisms, demonstrating significant protective effects in AKI models and preventing progression to chronic kidney disease. Furthermore, PTECs eliminate nearly 90% of CePPy within 14 days, indicating exceptional clearance efficiency. These findings highlight the potential of (+)CePPy as a promising therapeutic strategy for AKI, with significant implications for clinical translation.</description><dates><publication>2026/05/12</publication></dates><accession>GSE313051</accession><cross_references><GSM>GSM9359799</GSM><GSM>GSM9359800</GSM><GSM>GSM9359801</GSM><GSM>GSM9359802</GSM><GSM>GSM9359797</GSM><GSM>GSM9359798</GSM><GPL>34290</GPL><GSE>313051</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>